5:40 PM
 | 
Feb 16, 2012
 |  BC Extra  |  Company News

Newco Milo debuts to develop muscular dystrophy treatment

Milo Biotechnology LLC (Cleveland, Ohio) raised $250,000 in seed funding from the not-for-profit JumpStart Inc. The newco's lead product, AAV1-FS, is an adeno-associated...

Read the full 99 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >